Until today, I thought it was, in part, because the market makers wanted to keep our share price 5 times below the price of CYDY, which they have done, and which is because of our 1:5 reverse split.
But this week, we finally began to trade at greater than 5 times the price of CYDY shares. Which means, we were worth more than CYDY, net of the reverse split.
Do CYDY shareholders likely think that being selected for a NIH-sponsored trial would be a good thing, and cause a jump in share price? This CYDY shareholder would.
Do CYDY shareholders likely think that uplisting to NASDAQ would be a positive? I do.
Would a lower OS be good for CYDY share price, if it meant meeting the requirements for institutional buyers, who won't buy below $5.00 per share? I think that would be good.
So why has HGEN been trading at a lower adjusted share price compared to CYDY for so long?
It's because our share price has been manipulated by our market makers, whether it is because our market makers frequently short us, or it is on behalf of a Big Pharma that wants to buy us cheaply.
All I know is that I am thrilled to be trading at a higher share price than CYDY, because I think we are worth more than they are.
Just assume that market makers missed price change parity by one cent because that priced HGEN at $16.25, which proved to be our low of the day. If there was price change parity, then $16.25 would be the price I would watch for support and/or resistance for HGEN. Conversely, the CYDY price I would watch for support and/or resistance would be $2.19. CYDY has traded one 5 minute bar that hit $2.20, and all the rest of been lower than $2.19.
News 
Market Data 
Discover 
